Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
341.58
-6.28 (-1.81%)
Aug 6, 2026, 3:10 PM EDT - Market open
Bio-Rad Laboratories Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Bio-Rad Laboratories stock has a consensus rating of "Hold" and an average price target of $325. The average 1-year stock price forecast is 4.85% lower than the current stock price, while the lowest is $280 (-18.03%) and the highest is $370 (+8.32%).
Price Target: $325 (-4.85%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Bio-Rad Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 3 | 3 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $320 → $370 | Buy | Maintains | $320 → $370 | +8.32% | Aug 5, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $310 → $330 | Hold | Reiterates | $310 → $330 | -3.39% | Aug 5, 2026 |
| Citi | Citi | Hold Maintains $300 → $330 | Hold | Maintains | $300 → $330 | -3.39% | Aug 5, 2026 |
| Jefferies | Jefferies | Hold Maintains $275 | Hold | Maintains | $275 | -19.49% | May 21, 2026 |
Financial Forecast
Revenue This Year
2.58B
from 2.58B
Increased by 0.02%
Revenue Next Year
2.63B
from 2.58B
Increased by 1.93%
EPS This Year
9.64
from 9.92
Decreased by -2.81%
EPS Next Year
10.03
from 9.64
Increased by 4.01%
EPS and Forward PE are based on non-GAAP adjusted numbers.